SAMEC, Marek, Alena MAZURAKOVA, Vincent LUCANSKY, Lenka KOKLESOVA, Renata PECOVA, Martin PEC, Olga GOLUBNITSCHAJA, Raghad Khalid AL-ISHAQ, Martin CAPRNDA, Ludovit GASPAR, Robert PROSECKÝ, Katarina GAZDIKOVA, Mariusz ADAMEK, Dietrich BUESSELBERG, Peter KRUŽLIAK and Peter KUBATKA. Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2. European Journal of Pharmacology. AMSTERDAM: Elsevier, 2023, vol. 949, June 2023, p. 1-19. ISSN 0014-2999. Available from: https://dx.doi.org/10.1016/j.ejphar.2023.175655.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2
Authors SAMEC, Marek, Alena MAZURAKOVA, Vincent LUCANSKY, Lenka KOKLESOVA, Renata PECOVA, Martin PEC, Olga GOLUBNITSCHAJA, Raghad Khalid AL-ISHAQ, Martin CAPRNDA, Ludovit GASPAR, Robert PROSECKÝ (203 Czech Republic, belonging to the institution), Katarina GAZDIKOVA, Mariusz ADAMEK, Dietrich BUESSELBERG, Peter KRUŽLIAK (703 Slovakia, guarantor, belonging to the institution) and Peter KUBATKA.
Edition European Journal of Pharmacology, AMSTERDAM, Elsevier, 2023, 0014-2999.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.000 in 2022
RIV identification code RIV/00216224:14110/23:00131597
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.ejphar.2023.175655
UT WoS 001053815500001
Keywords in English Flavonoids; Cancer cells; Carcinogenesis; Metabolism; Metabolic reprogramming
Tags 14110116, 14110121, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/9/2023 10:47.
Abstract
Metabolic reprogramming of cancer cells is a common hallmark of malignant transformation. The preference for aerobic glycolysis over oxidative phosphorylation in tumors is a well-studied phenomenon known as the Warburg effect. Importantly, metabolic transformation of cancer cells also involves alterations in signaling cascades contributing to lipid metabolism, amino acid flux and synthesis, and utilization of ketone bodies. Also, redox regulation interacts with metabolic reprogramming during malignant transformation. Flavonoids, widely distributed phytochemicals in plants, exert various beneficial effects on human health through modulating molecular cascades altered in the pathological cancer phenotype. Recent evidence has identified numerous flavonoids as modulators of critical components of cancer metabolism and associated pathways interacting with metabolic cascades such as redox balance. Flavonoids affect lipid metabolism by regulating fatty acid synthase, redox balance by modulating nuclear factor-erythroid factor 2-related factor 2 (Nrf2) activity, or amino acid flux and synthesis by phosphoglycerate mutase 1. Here, we discuss recent preclinical evidence evaluating the impact of flavonoids on cancer metabolism, focusing on lipid and amino acid metabolic cascades, redox balance, and ketone bodies.
PrintDisplayed: 21/5/2024 20:48